In brief
A recent modelling study published in Nature Medicine predicts worldwide cervical‑cancer cases will climb 20.2 % and deaths will rise 39.3 % by 2050, even though the disease is largely preventable. Sub‑Saharan Africa is projected to see almost double its cases and deaths, with 206,000 deaths expected in 2050. The study calls for expanded HPV vaccination, screening and treatment worldwide.
A modelling study published in Nature Medicine predicts that worldwide cervical cancer will rise 20.2 % in cases and 39.3 % in deaths by 2050, according to a report by Xinhua dated November 3.
The research analysed global incidence, mortality and health loss for cervical cancer across 204 countries from 1990‑2023 and projected trends to 2050. It found 887,000 new cases and 369,000 deaths occurred worldwide in 2023. By 2050, annual cases are projected to reach 1.08 million and deaths 522,000.
The most pronounced increases are expected in sub‑Saharan Africa, where cases could rise by 88.7 % and deaths by 95.4 %, to an estimated 206,000 deaths in 2050; these figures were also highlighted by a medical news outlet, Medical Xpress, in a 10‑hour‑ago briefing.
The study noted that none of the seven global regions assessed is forecast to meet the World Health Organization’s cervical‑cancer elimination threshold of fewer than four cases per 100,000 women by 2050 under current trends.
“Access to HPV vaccination, screening and treatment varies widely around the world,” the authors wrote, stressing the need for broader implementation of these preventive measures.
In 2023, the age‑standardised incidence rate of cervical cancer was more than four times higher in low‑income countries than in high‑income countries, while the mortality rate was more than seven times higher, the study added.
